-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Maintains Buy on Collegium Pharmaceutical, Lowers Price Target to $46

Benzinga·08/06/2026 18:20:35
語音播報
Needham analyst Serge Belanger maintains Collegium Pharmaceutical (NASDAQ:COLL) with a Buy and lowers the price target from $56 to $46.